Aptamers
are nucleic acid-based affinity reagents that have been
incorporated into a variety of molecular sensor formats. However,
many aptamer sensors exhibit insufficient sensitivity and specificity
for real-world applications, and although considerable effort has
been dedicated to improving sensitivity, sensor specificity has remained
largely neglected and understudied. In this work, we have developed
a series of sensors using aptamers for the small-molecule drugs flunixin,
fentanyl, and furanyl fentanyl and compare their performancein
particular, focusing on their specificity. Contrary to expectations,
we observe that sensors using the same aptamer operating under the
same physicochemical conditions produce divergent responses to interferents
depending on their signal transduction mechanism. For instance, aptamer
beacon sensors are susceptible to false-positives from interferents
that weakly associate with DNA, while strand-displacement sensors
suffer from false-negatives due to interferent-associated signal suppression
when both the target and interferent are present. Biophysical analyses
suggest that these effects arise from aptamer–interferent interactions
that are either nonspecific or induce aptamer conformational changes
that are distinct from those induced by true target-binding events.
We also demonstrate strategies for improving the sensitivity and specificity
of aptamer sensors with the development of a “hybrid beacon,”
wherein the incorporation of a complementary DNA competitor into an
aptamer beacon selectively hinders interferentbut not targetbinding
and signaling, while simultaneously overcoming signal suppression
by interferents. Our results highlight the need for systematic and
thorough testing of aptamer sensor response and new aptamer selection
methods that optimize specificity more effectively than traditional
counter-SELEX.